Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KD-026 (SLx 4090), a microsomal triglyceride transfer protein (MTP) inhibitor(IC50 = 8.0 nM), is used in type 2 diabetes studies.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 37,500 | |||
5 mg | 在庫あり | ¥ 80,000 | |||
10 mg | 在庫あり | ¥ 127,500 | |||
25 mg | 在庫あり | ¥ 206,000 | |||
50 mg | 在庫あり | ¥ 282,500 | |||
100 mg | 在庫あり | ¥ 379,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 102,000 |
説明 | KD-026 (SLx 4090), a microsomal triglyceride transfer protein (MTP) inhibitor(IC50 = 8.0 nM), is used in type 2 diabetes studies. |
ターゲット&IC50 | ApoB:9.6 nM, MTP:8.0 nM |
別名 | SLx 4090, SLx4090, KD026, SLx-4090 |
分子量 | 546.54 |
分子式 | C31H25F3N2O4 |
CAS No. | 913541-47-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (100.63 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KD-026 913541-47-6 Metabolism CETP KD 026 SLx 4090 SLx4090 microsomal triglyceride transfer protein MTP inhibitor inhibit Inhibitor enterocytic-specific KD026 dyslipidemia SLx-4090 inhibitor